Speaker: Phillip K. Henderson, DO

Learning Objective: Discuss the issues and interventions currently available for the management of fatty liver disease, with a focus on available pharmacologic approaches.

Source: 2017 What’s New in GI Pharmacology Course

Explore the premier gastroenterology education site, the ACG Education Universe at http://universe.gi.org, for CME and thousands of other presentations by world experts in gastroenterology and hepatology.